Skip to content
OpenCapital
Get started

Boundless Bio, Inc. BOLD Q4 2025 Annual earnings

Reported March 9, 2026 · Before market open

EPS-$0.58Miss by $0.14
EPS estimate-$0.44

Next report

Aug 4, 2026 (In 6 days)
EPS estimate-$0.58

Versus estimates

Diluted EPS

Q1 2026-$0.60Miss by $0.09
Q4 2025-$0.58Miss by $0.14
Q3 2025-$0.62Miss by $0.09Q2 2025-$0.70Beat by $0.05Q1 2025-$0.71Miss by $0.03Q4 2024-$0.74In line

Ask the moment Boundless Bio, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Boundless Bio, Inc. report Q4 2025 earnings?
Boundless Bio, Inc. (BOLD) reported Q4 2025 earnings on March 9, 2026 before market open.
What were Boundless Bio, Inc.'s Q4 2025 revenue and EPS?
Boundless Bio, Inc. reported eps of $-0.58 for Q4 2025.
Did Boundless Bio, Inc. beat estimates in Q4 2025?
EPS missed the consensus estimate of $-0.44 by $0.14.
How did Boundless Bio, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 21.6% from $-0.74.
Where can I find Boundless Bio, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-097535) and the 10-K periodic report (0001193125-26-097543) directly on SEC EDGAR. The filing index links above go to sec.gov.